BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 217078)

  • 1. [Experimental neuropathy due to acrilamide. Histological and ultrastructural studies (author's transl)].
    Simonati A; Terzian H; Rizzuto N
    Riv Patol Nerv Ment; 1978 Sep; 98(4):213-27. PubMed ID: 217078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and morphological findings in acrylamide toxicity.
    Le Quesne PM
    Neurotoxicology; 1985; 6(4):17-24. PubMed ID: 4088539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow recovery of central axons in acrylamide neuropathy.
    Kaji R; Liu Y; Duckett S; Sumner AJ
    Muscle Nerve; 1989 Oct; 12(10):816-26. PubMed ID: 2558312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nervous system degeneration produced by acrylamide monomer.
    Spencer PS; Schaumburg HH
    Environ Health Perspect; 1975 Jun; 11():129-33. PubMed ID: 170076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphology of carbon disulfide neurotoxicity.
    Gottfried MR; Graham DG; Morgan M; Casey HW; Bus JS
    Neurotoxicology; 1985; 6(4):89-96. PubMed ID: 3003629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural changes in the peripheral nerves in experimental dying-back polyneuropathies.
    Prineas JW
    Proc Aust Assoc Neurol; 1971; 8():121-3. PubMed ID: 4341115
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord.
    Sills RC; Harry GJ; Morgan DL; Valentine WM; Graham DG
    Neurotoxicology; 1998 Feb; 19(1):117-27. PubMed ID: 9498228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental lead neuropathy: a disease of the supporting cells in the peripheral nervous system.
    Schlaepfer WW
    J Neuropathol Exp Neurol; 1969 Jul; 28(3):401-18. PubMed ID: 4307024
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene probe for P0 messenger RNA used to index acrylamide toxic neuropathy in rats.
    Veronesi B; Jones K; Gupta S; Pringle J; Mezei C
    Neurotoxicology; 1991; 12(4):715-32. PubMed ID: 1724557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
    Sickles DW
    Neurotoxicology; 1989; 10(1):91-101. PubMed ID: 2475836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed onset of distal axonal neuropathy in primates after prolonged low-level administration of a neurotoxin.
    Schaumburg HH; Arezzo JC; Spencer PS
    Ann Neurol; 1989 Oct; 26(4):576-9. PubMed ID: 2817831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The early phase of vincristine-induced neuropathy. Electrophysiological evidence of a "dying-back" phenomenon (author's transl)].
    Sebille A; Parlier Y
    Nouv Presse Med; 1981 Jul; 10(29):2417-20. PubMed ID: 6265865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral nerve pathology of experimental lead neuropathy (author's transl)].
    Matsuoka Y; Sobue I
    Rinsho Shinkeigaku; 1981 Jan; 21(1):56-63. PubMed ID: 6265133
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for direct axonal toxicity in vincristine neuropathy.
    Silva A; Wang Q; Wang M; Ravula SK; Glass JD
    J Peripher Nerv Syst; 2006 Sep; 11(3):211-6. PubMed ID: 16930282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurotoxic substances as a tool to understand some mechanisms of peripheral neuropathies (author's transl)].
    Sebille A; Hugelin A
    Pathol Biol (Paris); 1982 Jan; 30(1):37-41. PubMed ID: 6174920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral neuropathies. Current data concerning nerve regeneration (author's transl)].
    Sebille A
    Nouv Presse Med; 1982 Apr; 11(16):1206-15. PubMed ID: 6285276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model.
    George R; Griffin JW
    Exp Neurol; 1994 Oct; 129(2):225-36. PubMed ID: 7957737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cis-platinum-induced peripheral neuropathy. One case (author's transl)].
    Gastaut JL; Pellissier JF; Jean P; Tubiana N; Carcassonne Y
    Nouv Presse Med; 1982 Apr; 11(15):1113-7. PubMed ID: 6281722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.